Spondylarthritis
disease
Musculoskeletal Diseases
Disease or Syndrome
158
23
0.100
None
0.966
29
1999
2020
Spondylarthropathies
group
Musculoskeletal Diseases
Disease or Syndrome
92
7
0.100
None
1.000
24
1994
2020
Axial spondyloarthritis
disease
Musculoskeletal Diseases
Disease or Syndrome
67
0.100
None
1.000
21
2016
2020
Hypersensitive syndrome
disease
Immune System Diseases
Disease or Syndrome
17
2
0.100
None
1.000
19
2009
2019
Arthritis
disease
Musculoskeletal Diseases
Disease or Syndrome
1072
69
0.200
None
1.000
17
2002
2020
Uveitis
disease
Eye Diseases
Disease or Syndrome
247
43
0.100
None
0.938
16
1980
2020
melanoma
disease
Neoplasms
Neoplastic Process
3087
515
0.100
None
0.929
14
1994
2015
Drug Hypersensitivity Syndrome
disease
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
Disease or Syndrome
43
1
0.100
None
0.917
12
2014
2020
Ulcerative Colitis
disease
Digestive System Diseases
Disease or Syndrome
1458
827
0.100
None
1.000
11
1993
2017
Inflammatory disorder
group
Pathological Conditions, Signs and Symptoms
Disease or Syndrome
391
8
0.100
None
0.909
11
1995
2020
Exanthema
phenotype
Skin and Connective Tissue Diseases
Sign or Symptom
251
14
0.400
None
0.909
11
2006
2019
Drug-Induced Stevens Johnson Syndrome
disease
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
Disease or Syndrome
31
0.310
None
1.000
10
2004
2015
Drug-Induced Liver Disease
phenotype
Digestive System Diseases; Chemically-Induced Disorders
Disease or Syndrome
537
29
0.400
None
0.900
10
2009
2019
Epilepsy
disease
Nervous System Diseases
Disease or Syndrome
1215
339
0.100
None
1.000
10
2009
2019
Leukemia, Myelocytic, Acute
disease
Neoplasms
Neoplastic Process
3111
6892
0.090
None
1.000
9
1979
2019
leukemia
disease
Neoplasms
Neoplastic Process
2111
144
0.090
None
0.889
9
2002
2019
HIV disease progression
disease
Disease or Syndrome
54
5
0.090
None
1.000
9
2009
2018
Mycoplasma-Induced Stevens-Johnson Syndrome
disease
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
Disease or Syndrome
30
0.300
None
1.000
9
2004
2014
Myasthenia Gravis
disease
Neoplasms; Immune System Diseases; Nervous System Diseases
Disease or Syndrome
336
93
0.360
None
1.000
8
1983
2018
21-hydroxylase deficiency
disease
Disease or Syndrome
55
28
0.080
None
1.000
8
1978
1990
Acute anterior uveitis
disease
Eye Diseases
Disease or Syndrome
90
30
0.080
None
1.000
8
1980
2019
Malaria
disease
Infections
Disease or Syndrome
685
148
0.070
None
1.000
7
2005
2018
×
CUI:
C0030193
Disease:
Pain
Pain
phenotype
Pathological Conditions, Signs and Symptoms
Sign or Symptom
1554
196
0.070
None
1.000
7
2018
2020
Deficiency of steroid 21-monooxygenase
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
Congenital Abnormality
54
26
0.070
None
1.000
7
1978
1990
Malignant Neoplasms
group
Neoplasms
Neoplastic Process
8621
1641
0.070
None
1.000
7
2001
2017